Share
Embed
Transcript
150 slides
-
OK • – GKEAF • – ,+ deVa – –
– – 19/08/31 WS -
± • HJG HReZV e JVa ceVU GfeT V% ffi
– w – U.S. Food and Drug Administra:on (FDA). (2009). Guidance for Industry. U.S. Department of Health and Human Services. Pa:ent-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. hRps://www.fda.gov/downloads/drugs/guidances/ucm193282.pdf. . (2014). Patient Health Questionnaire (PHQ-9, PHQ-15) Generalized Anxiety Disorder-7 : up to date. , (7), 35-39. -
HJG • % ± u – u – • HJG
% u • –u • – ffi Mercieca-Bebber, R., King, M. T., Calvert, M. J., Stockler, M. R., & Friedlander, M. (2018). The importance of pa:ent- reported outcomes in clinical trials and strategies for future op:miza:on. Pa:ent related outcome measures, 9, 353. -
,5 ± 19/08/31 WS • ,% ffi • -% ffi
• .% 5 u u u – u u fi ʻ Elbers, R. G., Rietberg, M. B., van Wegen, E. E., Verhoef, J., Kramer, S. F., Terwee, C. B., & Kwakkel, G. (2012). Self-report fatigue questionnaires in multiple sclerosis, Parkinson’s disease and stroke: a systematic review of measurement properties. Quality of life research, 21(6), 925-944. -
https://www.cosmin.nl/book-measurement-in-medicine/ http://jabt.umin.ne.jp/j/activities/3-6journal.html ɹCOSMINɺईಛੑΛݕ౼͢Δ͏͑Ͱɺݚڀऀ͕ཹҙ͖͢Λ໌֬ʹ ͍ͯ͠Δ (, 2015) The COnsensus-based Standards for
the selection of health MeasurementINstruments (COSMIN) COSMINͷత: ݚڀྟচ࣮ફͰͷ࣭ͷߴ͍PROͷબΛଅਐ͢Δ͜ͱɻ -
kelk( v ( 1 : 10? 1 2: : 0?
3 - B 1 - 1 1A GKEAF ± ʻ 3VKFGMKOG HPS YTUGNCUKE GWKG T PH :VUEPNG GCTVSGNGOU OTUSVNGOUT 19/08/31 WS -
GKEAF Mokkink, L. B., Prinsen, C. A., Patrick, D. L.,
Alonso, J., Bouter, L. M., de Vet, H. C., & Terwee, C. B. (2018). COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs) – user manual. http://www.cosmin.nl/. ϢʔβʔϚχϡΞϧ 10εςοϓ -
GKEAF Mokkink, L. B., Prinsen, C. A., Patrick, D. L.,
Alonso, J., Bouter, L. M., de Vet, H. C., & Terwee, C. B. (2018). COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs) – user manual. http://www.cosmin.nl/. 10εςοϓ 8. 9. 10. A. B. C. PROM 5. 6. 7. 1. 2. 3. 4. -
Lee, J., Lee, E. H., & Moon, S. H. (2019).
Systematic review of the measurement properties of the Depression Anxiety Stress Scales–21 by applying updated COSMIN methodology. Quality of Life Research, 1-15. -
Lee, J., Lee, E. H., & Moon, S. H. (2019).
Systematic review of the measurement properties of the Depression Anxiety Stress Scales–21 by applying updated COSMIN methodology. Quality of Life Research, 1-15. 1. 2. 3. GRADE ΘΕ͍ͯΔํ๏ -
-5 Lee, J., Lee, E. H., & Moon, S. H.
(2019). Systematic review of the measurement properties of the Depression Anxiety Stress Scales–21 by applying updated COSMIN methodology. Quality of Life Research, 1-15. -
fifi – box1: 36 , box2: 31 1. PROMͷ։ൃ (box1)
༰తଥੑͷධՁ 2. ද໘తଥੑ (box2) తߏͷධՁ 3. ߏతଥੑ (box3) 4. త߹ੑ (box4) 5. ҟจԽؒଥੑ (box5) ͦͷଞͷಛੑධՁ 6. ৴པੑ (box6) 7. ଌఆޡࠩ (box7) 8. ج४ؔ࿈ଥੑ (box8) 9. ߏ֓೦ଥੑ(box9) 10. Ԡੑ (box10) ධՁ͢Δಛੑͷਪॱং Mokkink, L. B., Prinsen, C. A., Patrick, D. L., Alonso, J., Bouter, L. M., de Vet, H. C., & Terwee, C. B. (2018). COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs) – user manual. http://www.cosmin.nl/. -
PROMͷ࣭ͷධՁ 1. ݸʑͷݚڀͷόΠΞε ͷϦεΫͷධՁ 2. ࢦඪಛੑͷ࣭ΛධՁ 3. ΤϏσϯεͷ·ͱΊͱ ࣭ͷάϨʔσΟϯά Mokkink,
L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., ... & de Vet, H. C. (2010). The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of clinical epidemiology, 63(7), 737-745. 1. PROMͷ։ൃ (box1) ༰తଥੑͷධՁ 2. ද໘తଥੑ (box2) తߏͷධՁ 3. ߏతଥੑ (box3) 4. త߹ੑ (box4) 5. ҟจԽؒଥੑ (box5) ͦͷଞͷಛੑධՁ 6. ৴པੑ (box6) 7. ଌఆޡࠩ (box7) 8. ج४ؔ࿈ଥੑ (box8) 9. ߏ֓೦ଥੑ(box9) 10. Ԡੑ (box10) ධՁ͢Δಛੑͷਪॱং -
όΠΞεͷϦεΫ (risk of bias: RoB) ݚڀͷํ๏্ͷ࣭ͷߴʹΑͬͯɺݚڀݟͷ֬৴ͷΉ (όΠΞε)ͷͰɺݸʑͷݚڀͷ࣭ΛධՁ͠ΤϏσϯεͷ֬৴ධՁ ʹՃຯ͢Δɻ hRps://www.cosmin.nl/wp-content/uploads/COSMIN-RoB-checklist-V2-0-v17_rev3.pdf Mokkink,
L. B., De Vet, H. C., Prinsen, C. A., Patrick, D. L., Alonso, J., Bouter, L. M., & Terwee, C. B. (2018). COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Quality of Life Research, 27(5), 1171-1179. COSMINͰɺόΠΞεͷϦεΫͷνΣοΫϦετ͕උ - ֤ईಛੑʹෳͷධՁ߲ - ֤߲4݅๏ (very good, adequate, doubtful, inadequate)ͰධՁ -
TcZeVcZR W c U VRdfcV V e ac aVcej% Mokkink,
L. B., De Vet, H. C., Prinsen, C. A., Patrick, D. L., Alonso, J., Bouter, L. M., & Terwee, C. B. (2018). COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Quality of Life Research, 27(5), 1171-1179. COSMINͰɺࢦඪಛੑ͝ͱʹɺ ྑ͍ईಛੑධՁͷج४͕ ໌֬ʹࣔ͞Ε͍ͯΔɻ + sufficient (े) − insufficient (ෆे) ? indeterminate (ܾΊΒΕͳ͍) ྫ) ɹత߹ੑ: ΫϩϯόοΫͷα ͕ .80Ͱsufficient? ɹߏతଥੑ: CFI ͕.90ɺRMSEA͕10Ͱsufficient? 3ΧςΰϦධఆ [+ / - / ?] -
?J9< • Z Y E UVcReV D h NVcj h
• – u • • • % • % 19/08/31 WS -
• Lee, J., Lee, E. H., & Moon, S. H.
(2019). Systematic review of the measurement properties of the Depression Anxiety Stress Scales–21 by applying updated COSMIN methodology. Quality of Life Research, 1-15. -
y ffi ffi– de Vries, C. E. E., Kalff, M.
C., Prinsen, C. A. C., Coulman, K. D., den Haan, C., Welbourn, R., ... & van Wagensveld, B. A. (2018). Recommenda:ons on the most suitable quality-of-life measurement instruments for bariatric and body contouring surgery: a systema:c review. Obesity reviews, 19(10), 1395-1411. -
LR V V EVddR V • HJG GKEAF • u
• • ?J9< • – u – 19/08/31 WS -
GKEAF – Lee, J., Lee, E. H., & Moon, S.
H. (2019). Systematic review of the measurement properties of the Depression Anxiety Stress Scales–21 by applying updated COSMIN methodology. Quality of Life Research, 1-15. -
:k k – : : 1 :0: :3B 2: -
1 3 1 : 1 - 0 B :2 : GKEAF ± ʻ 3VKFGMKOG HPS YTUGNCUKE GWKG T PH :VUEPNG GCTVSGNGOU OTUSVNGOUT 19/08/31 WS -
• ffi (HJG ffi – i ( ( ( Terwee,
C. B., Prinsen, C. A., Chiarotto, A., Westerman, M. J., Patrick, D. L., Alonso, J., ... & Mokkink, L. B. (2018). COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Quality of Life Research, 27(5), 1159-1170. -
ؔ࿈ੑ (relevance) 1 ࢦඪʹؚ·Ε߲ͨɺؔ৺ͷ֓೦ʹؔ࿈͍ͯ͠Δ͔ 2 ࢦඪʹؚ·Ε߲ͨɺؔ৺ͷλʔήοτूஂʹؔ࿈͍ͯ͠Δ͔ 3 ࢦඪʹؚ·Ε߲ͨɺؔ৺ͷར༻จ຺ʹؔ࿈͍ͯ͠Δ͔ 4 Ԡબࢶద͔
5 ىظؒద͔ แׅੑ (comprehensiveness) 6 ॏཁͳ֓೦ͷ࿙Ε͕ͳ͍͔ ͔Γ͢͞ (comprehensibility) 7 ؔ৺ͷूஂ͕ҙਤͨ͠௨Γʹڭ͕ࣔཧղͰ͖Δ͔ 8 ؔ৺ͷूஂ͕ҙਤͨ͠௨Γʹ߲ͱԠબࢶ͕ཧղͰ͖Δ͔ 9 ߲ͷݴޠදݱ͕ద͔ 10 Ԡબࢶ࣭ͱϚον͍ͯ͠Δ͔ 19/08/31 WS -
Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso,
J., Stratford, P. W., Knol, D. L., ... & de Vet, H. C. (2010). The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of clinical epidemiology, 63(7), 737-745. Step1 • PROM։ൃͷ࣭ͷධՁ • (box1: όΠΞεͷϦεΫ) Step2 • ༰తଥੑݚڀͷ࣭ͷධՁ • (box2: όΠΞεͷϦεΫ) Step3 • ݚڀͷ࣭ͷධՁͱྑ͍ଥੑج४ͷධՁ • ͷ݁ՌΛ૯߹ධՁ -
Step1 (box1). PROM 1a. PROMͷؔ࿈ੑΛ૿ڧ͢ΔPROMઃ ܭͷ࣭ͷධՁج४ શൠతͳઃܭͷཁ ֓೦ੜ(ؔ࿈ੑͱแׅੑ) 1b. PROMͷ͔Γ͢͞ͱแׅੑΛධ
Ձ͢ΔͨΊͷɺೝతΠϯλϏϡʔଞ ͷύΠϩοτݚڀͷ࣭ͷධՁج४ શൠతͳઃܭͷཁ แׅੑ ͔Γ͢͞ Step2 (box2). ༰తଥੑݚڀͷ࣭ͷධՁ 2a. ؔ࿈ੑ (ױऀ) ߲ͷؔ࿈ੑΛױऀʹਘͶ͍ͯΔ 2b. แׅੑ (ױऀ) ߲ͷแׅੑΛױऀʹਘͶ͍ͯΔ 2c. ͔Γ͢͞ (ױऀ) ߲ͷ͔Γ͢͞ΛױऀʹਘͶ͍ͯΔ 2d. ؔ࿈ੑ (ઐՈ) ߲ͷؔ࿈ΛઐՈʹਘͶ͍ͯΔ 2e แׅੑ (ઐՈ) ߲ͷแׅੑΛઐՈʹਘͶ͍ͯΔ Terwee, C. B., Prinsen, C. A., Chiarotto, A., de Vet, H. C., Bouter, L. M., Alonso, J., ... & Mokkink, L. B. (2018). COSMIN methodology for assessing the content validity of PROMs–user manual. Amsterdam, Netherlands: VU University Medical Center. -
5KL H ,R Terwee, C. B., Prinsen, C. A., Chiarotto,
A., de Vet, H. C., Bouter, L. M., Alonso, J., ... & Mokkink, L. B. (2018). COSMIN methodology for assessing the content validity of PROMs–user manual. Amsterdam, Netherlands: VU University Medical Center. શൠతσβΠϯͷཁ ( ߲: 1-5) ඪతूஂ͕PROMͷ߲ ։ൃʹࢀՃ͍ͯ͠Δ͔(߲ 5) PROM։ൃͱͯ͠ෆద ͍ ͍͍͑ ߲6-13ΛධՁ -
5KL H ,R Terwee, C. B., Prinsen, C. A., Chiarotto,
A., de Vet, H. C., Bouter, L. M., Alonso, J., ... & Mokkink, L. B. (2018). COSMIN methodology for assessing the content validity of PROMs–user manual. Amsterdam, Netherlands: VU University Medical Center. શൠతσβΠϯͷཁ ( ߲: 1-5) ඪతूஂ͕PROMͷ߲ ։ൃʹࢀՃ͍ͯ͠Δ͔(߲ 5) PROM։ൃͱͯ͠ෆద ͍ ͍͍͑ ߲6-13ΛධՁ 1 ଌఆରͷ֓೦ʹ͍ͭͯ໌֬ͳهड़͕ͳ͞Ε͍ͯΔ͔ 2 ֓೦ͷഎܠ໌͔֬: ཧɺ֓೦తΈɺ࣬ױϞσϧ͕༻͍ΒΕ͍ͯΔ ଌఆ֓೦ͷఆٛʹؔ͢Δ໌֬Ͱ߹ཧతͳઆ໌͕ͳ͞Ε ͍ͯΔ 3 PROMΛ։ൃ͢Δλʔήοτूஂ͕໌֬ʹهड़͞Ε͍ͯ Δ 4 PROMΛ༻͢Δจ຺͕໌֬ʹهड़͞Ε͍ͯΔ 5 PROM։ൃݚڀ͕λʔήοτूஂΛද͢ΔඪຊͰ࣮ࢪ ͞Ε͍ͯΔ -
/(,5 – ( k f g i bicng ma WGSY
IPPF PS KOCFGRVCUGk 19/08/31 WS A (very good ra=ng) “ The PROMIS adult Pain Behavior item bank measures self-reported external manifesta:ons of pain: behaviors that typically indicate to others that an individual is experiencing pain. These ac:ons or reac:ons can be verbal or nonverbal, and involuntary or deliberate. They include observable displays (sighing, crying), pain severity behaviors (res:ng, guarding, facial expressions, and asking for help), and verbal reports of pain..” (hRps://www.assessmentcenter.net/documents/PROMIS Pain Behavior Scoring Manual.pdf) B (inadequate ra=ng) The Oswestry Disability Index (ODI) intends to measure disability. “By disability we mean the limita:ons of a pa:ent’s performance compared with that of a fit person” [43]. In this defini:on it is not clear what is considered ‘a pa:ent’s performance’ or ‘a fit person’. It is, for example, not clear whether it refers to physical limita:ons or (also) mental limita:ons. Therefore, it is difficult to rate the comprehensiveness of the PROM or to decide if an item on sleeping problems is relevant for the construct or not. -
/(-5 – ) ֓೦ͷഎܠ໌͔֬ WGSY IPPF PS FPVDUHVMk 19/08/31 WS
A. (very good ra=ng) The Menopause-Specific Quality Of Life (MENQOL) ques:onnaire is a condi:on-specific quality of life ques:onnaire, which was defined as “the extent that the physical, emo:onal and social aspects of an individual’s life are intact and not adversely affected by that condi:on or treatment”. The researchers aRributed each ques:on to one of five domains: physical, vasomotor, psychosocial, sexual and working life. It is unclear why these five domains were chosen and how they relate to the physical, emo:onal and social aspects of an individual’s life, as described in the defini:on of the construct [47]. B. (inadequate ra=ng) The conceptual model for the design of the Adolescent Cancer Suffering Scale was based on the components of the quality of life model in cancer survivors described by Ferrell. “Ferrell defined quality of life from a mul:dimensional perspec:ve including four domains of pa:ent well-being: physical, psychological, social and spiritual. Although dis:nct, each domain is able to influence the others. This model is par:cularly relevant to suffering because it recognizes its mul:dimensional aspect and because suffering could oren derive from a poor quality of life” [46]. -
/(.5 – λʔήοτूஂ͕໌֬ʹ WGSY IPPF PS KOCFGRVCUGk 4.จ຺͕໌֬ʹ WGSY IPPF
PS FPVDUHVMk The Copenhagen Hip and Groin Outcome Score (HAGOS) was developed for use in “young to middle-aged, physically ac:ve pa:ents with long-standing hip and/or groin pain” [49]. A. The Haemo-QoL Index was developed as a short measure for health-related quality of life assessment in children and adolescents with haemophilia. The instrument was developed to be used as a screening tool in daily clinical rou:ne, to be used in large clinical studies, and for comparing data across ages [50] B. Shapiro et al. developed a ques:onnaire for measuring fa:gue and sleepiness [51]. In the introduc:on of the paper they state: “Although researchers and clinicians have long recognized the importance of these deficit states, psychometrically sound measurement instruments have been lacking un:l recently. The present study was undertaken to develop a psychometrically sound instrument to obtain conceptually dis:nct measures of common facets of the energy deficit states described variously by terms such as fa:gue, sleepiness and :redness.“ It is not stated for which applica:on the PROM is to be developed. Some text in the discussion suggest that the PROM can be used for discrimina:on and evalua:on (“Future studies can contribute usefully by inves:ga:ng whether individuals in treatment for various diagnoses display differen:al responsiveness across subscales in response to alterna:ve treatments (e.g., insomnia vs. narcolepsy vs. chronic fa:gue syndrome). Future research can also contribute importantly by evalua:ng the sensi:vity of the FACES ques:onnaire to change (e.g., in clinical trials))” , but this is not clearly described. -
/(/5 – 5. PROM։ൃݚڀ͕λʔήοτूஂΛද͢ΔඪຊͰ࣮ࢪ (NVcj U 9UVbfReV < fSeWf A
RUVbfReV / ) 19/08/31 WS A. The Haemo-QoL Index was developed as a short measure for health-related quality of life assessment in children and adolescents with haemophilia. The instrument was developed to be used as a screening tool in daily clinical rou:ne, to be used in large clinical studies, and for comparing data across ages [50] B. To iden:fy how thyroid diseases impact the pa:ents’ lives and to select the most relevant quality of life (QoL) issues for a thyroid-specific ques:onnaire pa:ents were selected “by a nonrandom strategic sampling procedure, which aimed at maximizing the pa:ent varia:on as regards diagnoses, treatment, disease dura:on (including both newly diagnosed, untreated pa:ents and treated pa:ents), and age” [53]. -
5KL H ,R Terwee, C. B., Prinsen, C. A., Chiarotto,
A., de Vet, H. C., Bouter, L. M., Alonso, J., ... & Mokkink, L. B. (2018). COSMIN methodology for assessing the content validity of PROMs–user manual. Amsterdam, Netherlands: VU University Medical Center. શൠతσβΠϯͷཁ ( ߲: 1-5) ඪతूஂ͕PROMͷ߲ ։ൃʹࢀՃ͍ͯ͠Δ͔(߲ 5) PROM։ൃͱͯ͠ෆద ͍ ͍͍͑ ߲6-13ΛධՁ 6 ৽ن։ൃͷPROMͷؔ࿈߲Λಛఆ͢ΔͨΊʹదͳ࣭తͳσʔ λऩूํ๏͕༻͍ΒΕ͍ͯΔ͔ 7 ٕज़ͷ͋ΔάϧʔϓௐΠϯλϏϡΞʔ͕༻͍ΒΕ͍ͯΔ͔? 8 άϧʔϓϛʔςΟϯάΠϯλϏϡʔదͳτϐοΫΠϯλ ϏϡʔΨΠυʹج͍ͮͯͳ͞Ε͍ͯΔ͔ɻ 9 άϧʔϓϛʔςΟϯάΠϯλϏϡʔه͞ΕஞޠԽ͞Ε͍ͯ Δ͔ 10 σʔλʹదͳੳํ๏͕༻͍ΒΕ͍ͯΔ͔ 11 গͳ͘ͱσʔλͷҰ෦ͷίʔσΟϯάಠཱͯ͠ߦΘΕ͍ͯΔ 12 σʔλऩू͕(saturation)ʹୡ͢Δ·Ͱଓ͚ΒΕ͍ͯΔ 13 ྔతݚڀ(ௐࠪ)ͷ߹: αϯϓϧαΠζద͔ -
5KL H ,R Terwee, C. B., Prinsen, C. A., Chiarotto,
A., de Vet, H. C., Bouter, L. M., Alonso, J., ... & Mokkink, L. B. (2018). COSMIN methodology for assessing the content validity of PROMs–user manual. Amsterdam, Netherlands: VU University Medical Center. 6. HJGE ffi – ,5 • • – u ʼ – -5 • – z Very good Adequate Doubtful Inadequate ֘֓೦ͱݚڀର ʹ࣭తͳํ๏ʹ దͨ͠ɺ͘·ͨ ेʹਖ਼Խ͞ Ε࣭ͨతͳํ๏͕ ༻͍ΒΕ͍ͯΔ ֘֓೦ͱݚڀର ʹ࣭తͳํ๏ʹ ద࣭ͨ͠తͳํ๏ ͩͱߟ͑ΒΕΔ͕ɺ ໌֬ʹड़ΒΕͯ ͍ͳ͍ ྔతํ๏͚ͩ༻͍ ΒΕ͍ͯΔɺ͋Δ ֘ͷ֓೦ͱू ஂʹదͨ͠ํ๏Ͱ ͋Δ͔ٙΘ͍͠ ֘ͷ֓೦ͱूஂ ʹదͨ͠ํ๏Ͱ ͳ͍ -
5KL H ,R 7. HJGE ffi Very good Adequate Doubtful
Inadequate εΩϧͷ͋ΔௐΠϯλ ϏϡΞʔ͕༻͍ΒΕ͍ͯΔ ܦݧ͕ෆ͍ͯ͠Δ ܦݧ͕͋Δ͔ෆ໌͘͠ɺ ܇࿅ͳ͠ະܦݧऀ 8. v Very good Adequate Doubtful Inadequate దͳτϐοΫΠϯλ ϏϡʔΨΠυ͕༻͍ΒΕ ͍ͯΔ ͓ͦΒ͘τϐοΫΠϯ λϏϡʔΨΠυదͩ ͕໌֬ʹड़ΒΕ͍ͯͳ ͍ τϐοΫΨΠυ͕ͳ͍ɺ τϐοΫΨΠυΛ༻͍ ͔ͨෆ໌֬ɺτϐοΫΨ Πυͷదੑ͕ٙΘ͍͠ɺ ΨΠυ͕ͳ͍ 9. Very good Adequate Doubtful Inadequate શ͕ͯԻɺஞޠԽ͞Ε ͍ͯΔ ͓ͦΒ͘શ͕ͯԻɺஞ ޠԽ͞Ε͍ͯΔ͕هࡌ͕ ෆ໌֬ શ͕ͯԻɺஞޠ͞Εͯ ͍Δ͔ෆ໌֬ɺه͞Ε ͯΔ͚ͲஞޠԽ͞Ε͍ͯ ͳ͍ɺϊʔτ͚͕ͩͱΒ Ε͍ͯΔ ԿԻ͞Εͯͳ͍͠ ϊʔτʹऔΒΕ͍ͯͳ ͍ -
5KL H ,R • 11. ༰ੳ (content analysis): ֓೦/୯ޠ/ߦಈͷසूܭ͔Β৫Խ ԋ៷ੳ
(deductive analysis): Ծઆݕূతɺσʔλʹཧ/ݱ/֓೦Λ୳ٻ Έੳ (framework analysis): த৺ςʔϚɺ֓೦ʹैͬͯσʔλΛྨɺ৫Խ άϥϯσοτηΦϦʔ (grounded theory): ؼೲతʹσʔλऩूͱੳΛߦ͏࣭తݚڀ๏ ਪ: ࣭తݚڀ๏ͷΤΩεύʔτʹδϟοδΛґཔ Very good Adequate Doubtful Inadequate ͘ɺΑ͘ਖ਼Խ͞ ΕΔํ๏Λ༻͍͍ͯ Δ దͳΞϓϩʔνΛ ͓ͦΒ͘༻͍͍ͯΔ ͕هड़͕ෆ໌֬ ͲͷΑ͏ͳΞϓϩʔ νΛ༻͍ͨͷ͔ෆ໌ ֬ɺΞϓϩʔν͕ద ͔ٙΘ͍͠ Ξϓϩʔν͕దͰ ͳ͍ -
5KL H ,R • 11. – Very good Adequate Doubtful
Inadequate গͳ͘ͱσʔλ ͷ50%͕গͳ͘ͱ 2ਓͷಠཱͨ͠ݚ ڀऀʹΑͬͯධՁ ͞Ε͍ͯΔ σʔλͷ11%-49% ͕গͳ͘ͱ2ਓͷ ಠཱͨ͠ݚڀऀʹ ΑͬͯධՁ͞Εͯ ͍Δ ೋਓͷݚڀ͕ίʔ σΟϯάʹࢀՃ͠ ͍ͯΔ͔ٙΘ͍͠ɺ 1-10%ͷσʔλ͕ গͳ͘ͱ2ਓͷಠ ཱͨ͠ݚڀऀʹ ΑͬͯධՁ͞Εͯ ͍Δ Ұਓͷݚڀऀ͚ͩ ͕ίʔσΟϯάʹ ؔΘ͍ͬͯΔɺ ίʔσΟϯά͕͞ Ε͍ͯͳ͍ • 13. % 5 Very good Adequate Doubtful Inadequate ≥100 50-99 30-49 Not applicable -
5KL H ,R • 12. dRefcReZ % Very good Adequate
Doubtful Inadequate ʹୡͨ͠Τ Ϗσϯε͕ࣔ͞ Ε͍ͯΔ ͓ͦΒ͘ʹ ୡ͍ͯ͠Δ ʹୡ͔ͨ͠ Ͳ͏͔ٙΘ͍͠ ʹୡ͍ͯ͠ ͳ͍ͱΤϏσϯ ε͕͍ࣔͯ͠Δ (saturation): ͜ΕҎ্ΠϯλϏϡʔΛଓ͚ͯ৽ͨͳݟɺ ֓೦ɺΧςΰϦʔ͕ग़ͯ͜ͳ͘ͳΔঢ়ଶ Α͘༻͍ΒΕΔΤϏσϯε. τϥϯεΫϦϓτͷ֤ ηοτͷίʔυΛલͷά ϧʔϓͷίʔυͱൺֱ͠ɺ άϦουΛࣔ͢ 4 -
5KL H ,S ೝతΠϯλϏϡʔύΠϩοτςετͷ࣮ࢪ (߲14) ױऀ͕แׅੑΛਘͶΒ Ε͍ͯΔ(߲ 16) PROM։ൃͱͯ͠ෆద ͍
͍͍͑ ߲15ΛධՁ ͍ ͍͍͑ ? ױऀ͕͔Γ͢͞ΛਘͶ ΒΕ͍ͯΔ(߲ 26) ͍ ͍͍͑ ? ߲17-25ΛධՁ ߲27-35ΛධՁ PROM։ൃ ͱͯ͠ෆద ࠷ऴతͳධՁΛܾఆ (ϫʔετείΞΛΧϯτ͢Δ) -
ೝతΠϯλϏϡʔύΠϩοτςετͷ࣮ࢪ (߲14) ױऀ͕แׅੑΛਘͶ ΒΕ͍ͯΔ(߲ 16) PROM։ൃͱͯ͠ෆద ͍ ͍͍͑ ߲15ΛධՁ ͍
͍͍ ͑ ? ױऀ͕͔Γ͢͞Λ ਘͶΒΕ͍ͯΔ(߲ 26) ͍ ͍͍ ͑ ? ߲17-25ΛධՁ ߲27-35ΛධՁ PROM։ൃ ͱͯ͠ෆద ࠷ऴతͳධՁΛܾఆ (ϫʔετείΞΛΧϯτ͢Δ) 5KL H ,S 27 28 PRO (18 ) 29 30 ? 31 32 33 34 35 PROM PRO 17 શͯͷ߲͕࠷ऴ൛Ͱݕূ͞Ε͍ͯΔ 18 PROͷڭࣔɺ߲ɺԠબࢶɺىظؒͷ͔Γ͢ ͞ΛධՁ͢ΔͨΊʹదͳ࣭తํ๏͕༻͍ΒΕ͍ͯΔɻ 19 దͳױऀͷͰ֤߲͕ݕূ͞Ε͍ͯΔ ࣭తݚڀͷ߹ ྔతݚڀͷ߹ 20 ٕज़ͷ͋ΔάϧʔϓௐΠϯλϏϡΞʔ͕࣋ͪΒΕ ͍ͯΔ͔? 21 άϧʔϓϛʔςΟϯάΠϯλϏϡʔదͳτϐοΫ ΠϯλϏϡʔΨΠυʹج͍ͮͯͳ͞Ε͍ͯΔ͔ɻ 22 άϧʔϓϛʔςΟϯάΠϯλϏϡʔه͞ΕஞޠԽ ͞Ε͍ͯΔ͔ 23 σʔλʹదͳੳํ๏͕༻͍ΒΕ͍ͯΔ͔ 24 গͳ͘ͱೋਓͷݚڀऀ͕ղੳʹࢀՃ͍ͯ͠Δɻ 25 ͦͷPROMΛױऀʹద༻͢Δ߹ʹPROͷڭࣔɺ߲ɺ Ԡબࢶɺىظؒͷ͔Γ͢͞ʹؔ͢Δ͕͋ Δ͔ɻ 20 23 30 33 Step1a 7 10 ( ) -
5KL H ,S • 17 or 27 Very good Adequate
Doubtful Inadequate શͯͷ߲͕࠷ऴ൛Ͱς ετ͞ΕͯΔ ͓ͦΒ͘࠷ऴ൛͕ͩ໌֬ ʹهࡌ͞Ε͍ͯͳ͍ ࠷ऴ൛Ͱςετ͔ͨ͠Ͳ ͏͔ෆ໌֬ ࠷ऴ൛Ͱςετ͞Ε͍ͯ ͳ͍ ඍௐ͞Εͨޙʹ࠶ςε τ͕ͳ͞Ε͍ͯͳ͍ • 18 or 28.Θ͔Γ͢͞แׅੑධՁͷͨΊʹదͳํ๏͕༻͍ΒΕ͍ͯ Δ Very good Adequate Doubtful Inadequate ͘ΒΕɺेʹਖ਼ Խ͞Ε͍ͯΔ࣭తݚڀ๏ ͕࣋ͪΒΕ͍ͯΔ దͳํ๏͕༻͍ΒΕͯ ͍ΔͱࢥΘΕΔ͕ɺ໌֬ ͳهࡌ͕ͳ͍ ྔతͳ(ௐࠪ)ํ๏ͷΈ͕ ༻͍ΒΕ͍ͯΔɺํ๏͕ ద͔ٙΘ͍͠ɺױऀ͕ ͔Γ͢͞แׅੑʹ ͍ͭͯਘͶΒΕ͔ͨෆ໌ ֬ɺਘͶΒΕ͍ͯͳ͍ ෆదͳํ๏͕༻͍ΒΕ ͍ͯΔ -
5KL H ,S • 19 or 29. Very good Adequate
Doubtful Inadequate ࣭తݚڀͷ߹ ≥7 ྔతݚڀͷ߹ ≥50 ࣭తݚڀͷ߹ 4-6 ྔతݚڀͷ߹ ≥30 ࣭తݚڀͷ߹ <4 or ෆ໌ ྔతݚڀͷ߹ <30 or ෆ໌ • 24 or 34. – v Very good Adequate Doubtful Inadequate গͳ͘ͱೋਓ ͷݚڀऀ͕ղੳ ʹࢀՃ͍ͯ͠Δ গͳ͘ͱೋਓ ͷݚڀऀ͕ղੳ ʹࢀՃ͍ͯ͠Δ ͱࢥΘΕΔ͕ه ࡌ͕ෆ໌֬ ೋਓࢀՃ͔ͨ͠ ෆ໌ɺͻͱΓͩ ͚ࢀՃ -
5KL H ,S • 25 or 35. HJGE HJG u
u u ff v Very good Adequate Doubtful Inadequate ͳ͠ɺ ͕໌ࣔ͞Εɺ ௐ͞Εɺඞཁ ͳ߹ʹ࠶ςε τ͞Ε͍ͯΔ ͳ͍Α͏ʹ ࢥΘΕΔ͕ɺ͋ Δ͍͕ద ʹݴٴ͞Εͯ ͍Δ͕ɺهࡌ͕ ෆ໌֬ ͕͋Δͷ͔ ෆ໌֬ɺ͕ ͋Δ߹ʹ໌ࣔ ͞Ε͍ͯΔ͔ٙ Θ͍͠ɺ͕ ͋ͬͨ߹ʹௐ ͕͞Ε͍ͯΔ ͕ɺมߋޙʹ࠶ ςετ͕͞Εͯ ͍ͳ͍ɻ ͕͖͋Β͔ʹ͋Δ -
5KL H - Terwee, C. B., Prinsen, C. A., Chiarotto,
A., de Vet, H. C., Bouter, L. M., Alonso, J., ... & Mokkink, L. B. (2018). COSMIN methodology for assessing the content validity of PROMs–user manual. Amsterdam, Netherlands: VU University Medical Center. -
5KL H - Terwee, C. B., Prinsen, C. A., Chiarotto,
A., de Vet, H. C., Bouter, L. M., Alonso, J., ... & Mokkink, L. B. (2018). COSMIN methodology for assessing the content validity of PROMs–user manual. Amsterdam, Netherlands: VU University Medical Center. Step2a, b, c 1, 8, 15 2, 9, 16 3, 10, 17 ? 4, 11, 18 5, 12, 19 6, 13, 20 7, 14, 21 Step2d,e 22, 27 23, 28 24, 29 25, 30 26, 31 • ߲step1ͱڞ௨ -
5KL H . • UG C+ ,+ – u HJGE
v u HJGE v • UG D+ u u u u dfrTZV e &% Z dfrTZV e o% Z T dZdeV e p% c Z UVeVc Z ReV 8% • UG E+ – KeVa .S • YZ Y UVcReV h gVcj h • ffi 19/08/31 WS -
5 KeVa.R 19/08/31 WS TV EKGOU – HJG % 30
KOTV EKGOU – HJG % 30 , KOFGUGSNKOCUG u ධՁͷࡍʹɺόΠΞεͷϦεΫͷධՁΛՃຯ ݚڀσβΠϯ͕ෆదͱධՁ͞Εͨͷɺ͜ͷධՁΛߦΘͳ͍ (εϥΠυ28,40ͷϑϩʔͰPROͱͯ͠ෆదͱධՁ͞Εͨͷ) -
5 KeVa.R ؔ࿈ੑ (relevance) 1 ࢦඪʹؚ·Ε߲ͨɺؔ৺ͷ֓೦ʹؔ࿈͍ͯ͠Δ͔ 2 ࢦඪʹؚ·Ε߲ͨɺؔ৺ͷλʔήοτूஂʹؔ࿈͍ͯ͠Δ͔ 3 ࢦඪʹؚ·Ε߲ͨɺؔ৺ͷར༻จ຺ʹؔ࿈͍ͯ͠Δ͔
4 Ԡબࢶద͔ 5 ىظؒద͔ ֤߲Λ + (sufficient), - (insufficient), ± (indeterminate)ͰධՁ O P 1 : 63 ) ( - ) ( - 5 Step1a Step2 -
dfrTZV e &% 19/08/31 WS PROM development study Content validity
study Reviewers’ rating 1 Very good on Box1.1 and Box1.2 (ଌఆ֓೦ͱͦͷഎܠ͕ΫϦΞ) Not inadequate on box 2d. 22-26 (ؔ࿈ੑ:ઐՈ) গͳ͘ͱ߲ͷ85%͕ؔ৺ͷ ֓೦Λࢦͯ͠Δ গͳ͘ͱ߲ͷ85%͕ؔ ৺ͷ֓೦Λࢦͯ͠Δ গͳ͘ͱ߲ͷ85%͕ؔ ৺ͷ֓೦Λࢦͯ͠ΔͱϨ Ϗϡϫʔஅ 2 Box1.3 and very good (ඪతू ஂ͕໌֬) Box1.5 very good or adequate (ඪతूஂ͕߲ੜؔ༩) Box1a 6-13 not inadequate (ؔ ࿈ੑ) ඪతूஂͷදੑ͕ٙΘ͍͠ → ? not inadequate on Box2a1-7 (ױऀධՁͷؔ࿈ੑ) গͳ͘ͱ85%ͷ߲͕ؔ ࿈ੑ͋Γ গͳ͘ͱ߲ͷ85%͕ؔ ৺ͷूஂͱؔ࿈ͱϨϏϡ ϫʔஅ -
dfrTZV e &% T e)% 19/08/31 WS PROM development study
Content validity study Reviewers’ rating 3 Box1.4 very good (༻จ ຺͕໌֬) not inadequate on Box2a22-26 (ઐՈධՁͷؔ ࿈ੑ) গͳ͘ͱ85%ͷ߲͕ؔ࿈ ੑ͋Γ গͳ͘ͱ߲ͷ85%͕ؔ৺ ͷจ຺ͱؔ࿈ͱϨϏϡϫʔ அ 4 Ԡબࢶͷਖ਼ੑ͕ࣔ͞ Ε͍ͯΔ Not inadequate on Box2a 1-7 and Box2d 22-26 ױऀͱઐՈ͕ԠબࢶΛ దͩͱධՁ গͳ͘ͱ85%ͷԠΦϓ γϣϯ͕ؔ࿈͍ͯ͠Δ গͳ͘ͱԠબࢶͷ85% ͕֓೦ɺूஂɺ༻จ຺ͱؔ ࿈͍ͯ͠ΔͱϨϏϡΞʔஅ 5 ىظؒͷਖ਼ੑ͕ࣔ͞Ε ͍ͯΔ Not inadequate on Box2a 1-7 and Box2d 22-26 ױऀͱઐՈ͕ىظؒΛద ͩͱධՁ গͳ͘ͱىظ͕ؒ֓೦ɺ ूஂɺ༻จ຺ͱؔ࿈͍ͯ͠ ΔͱϨϏϡΞʔஅ -
5 KeVa.R ֤߲Λ + (sufficient), - (insufficient), ± (indeterminate)ͰධՁ Step1b
Step2 1 5 4 - P M 4 )3 M6 R 4 ? R ( - P M 4 R ( 4 ? 4 ? )3 M6 7 1O? 2 แׅੑ (comprehensiveness) 6 ॏཁͳ֓೦ͷ࿙Ε͕ͳ͍͔ -
dfrTZV e &% 19/08/31 WS PROM development study Content validity
study Reviewers’ rating 6 Not inadequate on box 1a standards 6-13 box 1b standards 26-35 ױऀ͕แׅੑʹ͍ͭͯɺ ֓೦ੜϑΣʔζೝ తΠϯλϏϡʔͰਘͶΒ Ε͓ͯΓ ॏཁͳ֓೦ͷ࿙Ε͕ͳ͍ Not inadequate box 2b standards 8-14 box 2e standards 27-31 ױऀͱઐՈ͕แׅੑʹͭ ͍ͯਘͶΒΕ͓ͯΓ धཁͳ֓೦ͷ࿙Ε͕ͳ͍ ϨϏϡΞʔ PRO͕ɺ֓೦ɺ ରɺ༻จ ຺ͱরΒͯ͠ แׅతଥͱ ߟ͍͑ͯΔ -
͔Γ͢͞ (comprehensibility) 7 ؔ৺ͷूஂ͕ҙਤͨ͠௨Γʹڭ͕ࣔཧղͰ͖Δ͔ 8 ؔ৺ͷूஂ͕ҙਤͨ͠௨Γʹ߲ͱԠબࢶ͕ཧղͰ͖Δ͔ 9 ߲ͷݴޠදݱ͕ద͔ 10 Ԡબࢶ࣭ͱϚον͍ͯ͠Δ͔
19/08/31 WS Step1b Step2 1 5 4 - P M 4 )3 M6 R 4 ? R ( - P M 4 R ( 4 ? 4 ? )3 M6 7 1O? 2 -
dfrTZV e &% 19/08/31 WS PROM development study Content validity
study Reviewers’ rating 7 Not inadequate on Box1b.16-25 ױऀ͕ڭࣔͷ͔Γқ͞ʹ͍ͭͯ(ىظؒΛؚΊ ͯ)ɺ֓೦ੜϑΣʔζೝతΠϯλϏϡʔͰਘͶ ΒΕ͓ͯΓ ͕దʹ໌ࣔ͞Ε͍ͯΔ Not inadequate on Box2c.15-21 ױऀ͕ڭࣔͷ͔Γқ͞ʹ͍ͭͯ( ىظؒΛؚΊͯ)ɺ༰తଥੑݚڀ ͰਘͶΒΕ͓ͯΓ ॏཁͳ͕ͳ͍ 8 Not inadequate Box1b.16-25 ױऀ͕߲ͱԠબࢶͷ͔Γқ͞ʹ͍ͭͯ(ى ظؒΛؚΊͯ)ɺ֓೦ੜϑΣʔζೝతΠϯλ ϏϡʔͰਘͶΒΕ͓ͯΓ ͕దʹ໌ࣔ͞Ε͍ͯΔ Not inadequate Box2c.15-21 ױऀ͕߲ͱԠબࢶͷ͔Γқ ͞ʹ͍ͭͯ(ىظؒΛؚΊͯ)ɺ༰ తଥੑݚڀͰਘͶΒΕ͓ͯΓ গͳ͘ͱ85%ͷ߲ͱԠબࢶ ʹॏཁͳ͕ͳ͍ ϨϏϡΞʔগͳ͘ͱ ߲ͷ85%͕ؔ৺ͷ ༻จ຺ͱؔ࿈͍ͯ͠ Δͱߟ͍͑ͯΔ 9 ϨϏϡΞʔগͳ͘ͱ ߲ͱԠબࢶͷ 85%͕ɺదʹϫʔ σΟϯά͞Ε͍ͯΔͱ ߟ͍͑ͯΔ 10 ϨϏϡΞʔগͳ͘ͱ Ԡબࢶͷ85%͕ɺ దʹϫʔσΟϯά͞ Ε͍ͯΔͱ࣭ͱϚο ν͍ͯ͠Δͱߟ͍͑ͯ Δ -
KeVa .S5 19/08/31 WS + - ? ± ؔ࿈ੑ গͳ͘ͱج४1ͱ
2(+) AND ଞͷ3ͭͷج४Ͱগ ͳ͘ͱ2ͭ(+) 1ͱ2Ҏ֎Ͱͷ(-) Ұͭ·Ͱڐ༰ (-)͕͍ͭͨ߹ ±ͷධՁϨϏϡ ϫʔՄೳ গͳ͘ͱج४1ͱ2ͷ ͲͪΒ͔ʹ(-) AND ଞͷ3ͭͷج४ͷগͳ ͘ͱ2ͭͰ (-) গͳ͘ͱ̎ͭ ج४ΛධՁ ͦͷଞͷঢ়گ แׅੑ ج४6ͷධՁ ج४6ͷධՁ ج४6ͷධՁ ج४6ͷධՁ ͔Γ͢͞: PROM։ൃ ༰తଥੑݚڀ গͳ͘ͱج४8͕ (+)Ͱج४7͕(–) ͡Όͳ͍ ج४8͕(-) ج४8͕ධՁ͞Ε ͯΔ ج४8͕(+)Ͱج४7 ͕ධՁ͞ΕͯΔ ͔Γ͢͞ɿ ϨϏϡϫʔධՁ ج४9ͱ10͕(+) ج४9ͱ10͕(-) গͳ͘ͱͲͪ Β͔͕ධՁ͞Ε ͯΔ Ұํ͕(+)Ͱ͏Ұ ํ͕(-) -
KeVa .S5 – p% 19/08/31 WS Ұ؏͠ͳ͍ཧ༝Λݕ౼ɿ ඞཁʹԠͯ͡ɺͦͷཁҼͰαϒάϧʔϓΛߏ͠ධՁ ྫ) ͠ɺٸੑױऀͱຫੑױऀͰҟͳΔධՁ͕༩͑
ΒΕ͍ͯΔͳΒɺPROͷ༰తଥੑͷ૯߹ධ ՁɺٸੑױऀͱຫੑױऀͰ͚ͯΔɻ ٸੑױऀͰแׅੑͷ૯߹ධՁ͕(+)Ͱ͋Δ͕ɺ ຫੑױऀͰʢ-) -
KeVa .T5 • 19/08/31 WS ݚڀσβΠϯ ༰తଥੑݚڀগͳ͘ ͱҰͭ High όΠΞεͷϦεΫ
1. Serious 2. Very serious 3. Very serious टඌҰ؏ੑ 1. Serious 2. Very Serious ඇੑ 1. Serious 2. Very Serious ༰తଥੑݚڀͳ͠ Moderate low Very low -
KeVa .T5 19/08/31 WS 1 very good adequate 1 doubtul
1 PROM very good or adequate 1 PROM doubtul 1 PROM inadequate -1 -2 -3 -
KeVa .T5 • – – u u – v •
– u v 19/08/31 WS -
LR V Y V VddR V • – • ffi
u u • u u u • u • 19/08/31 WS -
: povk vsyq s v : :2 . - 1
GKEAF ± ʻ 3VKFGMKOG HPS YTUGNCUKE GWKG T PH :VUEPNG GCTVSGNGOU OTUSVNGOUT 19/08/31 WS -
PROMͷ࣭ͷධՁ 1. ݸʑͷݚڀͷόΠΞε ͷϦεΫͷධՁ 2. ࢦඪಛੑͷ࣭ΛධՁ 3. ΤϏσϯεͷ·ͱΊͱ ࣭ͷάϨʔσΟϯά Mokkink,
L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., ... & de Vet, H. C. (2010). The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of clinical epidemiology, 63(7), 737-745. 1. PROMͷ։ൃ (box1) ༰తଥੑͷධՁ 2. ද໘తଥੑ (box2) తߏͷධՁ 3. ߏతଥੑ (box3) 4. త߹ੑ (box4) 5. ҟจԽؒଥੑ (box5) ͦͷଞͷಛੑධՁ 6. ৴པੑ (box6) 7. ଌఆޡࠩ (box7) 8. ج४ؔ࿈ଥੑ (box8) 9. ߏ֓೦ଥੑ(box9) 10. Ԡੑ (box10) ධՁ͢Δಛੑͷॱং -
• u GKEAF -++4% • – v • GKEAF -++4%
v • u 19/08/31 WS -
• ffi – – t Terwee, C. B., Prinsen, C.
A., Chiarotto, A., Westerman, M. J., Patrick, D. L., Alonso, J., ... & Mokkink, L. B. (2018). COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Quality of Life Research, 27(5), 1159-1170. formative model reflective model :69 78;7 ' &!$ 0 &"$ 20 &#$ 0 :69 78;7 ' %!$ 0 %"$ 0 %#$ ε ε ε ε formative reflective ⇒ ⇒ CTT, IRT 01,0/ 5)4 0/<,00 * +4-13.( Reflective model͕ධՁର -
19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ (doubtful) ෆద
(inadequate) 1. ݹయతςετཧ: ୳ࡧత, ݕূతҼࢠੳ͕࣮ߦ͞Ε͍ͯΔ͔ɻ CFA࣮ࢪ EFA࣮ࢪ ͍ͣΕͳ͠ 2. IRT/Rash: બͨ͠Ϟσϧ͕ݚڀٙʹϑΟοτ͍ͯ͠Δ͔* બͨ͠Ϟσϧ ͕ϑΟοτͯ͠ Δ ͓ͦΒ͘ ϑΟοτͯ͠Δ ϑΟοτͯ͠Δ ͔ٙΘ͍͠ ϑΟοτͯ͠ͳ ͍ϞσϧΛબ ͯ͠Δ 3. ղੳରͷαϯϓϧαΠζద͔ ɻ ৄࡉ࣍ͷεϥΠυ 4. ଞͷॏཁͳݚڀσβΠϯ౷ܭख๏ͷ͕ܽؕ͋Δ͔ɻ ଞͷॏཁͳܽؕ ͳ͍ ଞͷܰඍͳํ๏ ͷ͕ܽؕ͋Δ (e.g., ճస๏͕هࡌ͞ Ε͍ͯͳ͍) ଞͷॏཁͳܽؕ ͕͋Δ(e.g.,ෆద ͳճస๏ͷ༻) *ϑΥϩΞοϓσʔλΛՃ͑ͯղੳͯ͠Δ߹ɺ ϚϧνϨϕϧIRT͕దͳͷʹద༻ͯ͠ͳ͍ͳͲ -
,) 1. ݹయతςετཧ: ୳ࡧత, ݕূతҼࢠੳ͕࣮ߦ͞Ε͍ͯΔ ͔ɻ 19/08/31 WS item 5
item 6 item 2 item 1 item 3 item 4 f1 f2 EFA CFA CFA item 5 item 6 item 2 item 1 item 3 item 4 f1 f2 -
LL AJL X5 X6 X2 X1 X3 X4 θi CTT
e5 e6 e2 e1 e3 e4 IRT Z5 Z6 Z2 Z1 Z3 Z4 θi CTT IRT Xij : i j ( ) μj j αj j Θi i ej j Zij : i j (2 / ) αj j ( ) βj j Θi i ( ) ej j Z 2 : Rash / 1-PL / 2-PL / 3PL Z : Graded Response Model (GRM)/ Par:al Credit Response Model (PCRM) Xij = μj +αj θi + eij α1 α2 α3 α4 α5 α6 β1 β2 β3 β4 β5 β6 e5 e6 e2 e1 e3 e4 Zij = -αj +βj θi + eij ( ) -
AJL5 - a j = β j = ߲ಛੑۂઢͷ͖ ߲ಛੑۂઢͷย
IRT Z5 Z6 Z2 Z1 Z3 Z4 θi β1 β2 β3 β4 β5 β6 e5 e6 e2 e1 e3 e4 Zij = -αj +βj θi + eij (item characteris:c curve: ICC) -
19/08/31 WS (very good) (adequate) (doubHul) (inadequate) 3. Factor analysis
߲ͷ7ഒ ≧100Ҏ্ ߲ͷ5ഒ͔ ͭ≧100 or ߲ͷ5-7ഒ ͔ͭ<100 ߲ͷ5ഒ <100ҎԼ ߲ͷ5ഒҎ Լ Rasch/1PL model 200Ҏ্ 100-199 50-99 <50 2 PL parametric IRT model Mokken scale analysis 1000Ҏ্ 500-999 250-499 <250 -
19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ (doubtful) ෆద
(inadequate) 1. త߹ੑͷ౷ܭࢦඪ͕୯Ұ࣍ݩई·ͨԼҐई͝ͱͰࢉग़͞Εͯ Δ ࢉग़͞ΕͯΔ ईશମ͔ԼҐई ͳͷ͔ෆ໌ ࢉग़͞Εͯͳ͍ 2. ࿈ଓείΞͷ߹: ΫϩϯόοΫͷα·ͨϚΫυφϧυͷω͕ࢉग़͞Ε ͯΔ ࢉग़͞Ε͍ͯΔ ITT૬͚ؔͩࢉग़͞ Ε͍ͯΔ ͲͪΒࢉग़͞Ε ͯͳ͍ 3. ೋείΞͷ߹ɿΫϩϯόοΫͷα·ͨKR-20͕ࢉग़͞Ε͍ͯΔ ࢉग़͞Ε͍ͯΔ ITT૬͚ؔͩࢉग़͞ Ε͍ͯΔ ͲͪΒࢉग़͞Ε ͯͳ͍ 4. IRTʹجͮ͘είΞͷ߹ɿೳྗ(θ)ͷඪ४ޡࠩ(SE(θ))ͳͲͷજࡏಛੑ ͷ৴པੑ͕ࢉग़͞Ε͍ͯΔ ࢉग़͞Ε͍ͯΔ ࢉग़͞Ε͍ͯͳ͍ -
s V R k = ߲૯ σ2 i = ߲iͷࢄ
σ2 test = ߹ܭಘͷࢄ ΫϩϯόοΫͷα: Ҽࢠෛՙ߲ؒͰ͍͠ͱ͍͏લఏ͋Γ λ j = ߲jͷҼࢠෛՙ (ඪ४Խ) σ2 εi = ߲ j ͷޡࠩࢄ 1 ϚΫυφϧυͷω:Ҽࢠෛՙ߲ؒͰҟͳ͍ͬͯͯྑ͍ CFAద༻ͷ߹ɺω͕ద -
s CJ(-+ https://researchmap.jp/muuex8xf9-1788230/? action=multidatabase_action_main_filedownload&download_flag=1&upload_id=65193&metadata_id=49144 k = ߲૯ σ2 i =
߲iͷࢄ σ2 test = ߹ܭಘͷࢄ ΫϩϯόοΫͷα: ࿈ଓมͷ߹ k = ߲૯ pi = ͍(1)ͱճͨ͠ਓͷׂ߹ qi = ͍͍͑(0)ͱճͨ͠ਓͷׂ߹ σ2 test = ߹ܭಘͷࢄ KR-20: 2มͷ߹ -
AJL ೳྗͷඪ४ޡࠩ (SE (θ)) SE(θ) = 1/√ I(θ) I(θ) :
ϑΟογϟʔใྔؔ ೳྗ͕֘ͷͰͲΕ͘Β͍ਖ਼͔֬ ςετใۂઢ -
ff ffi 19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ
(doubtful) ෆద (inadequate) 1. άϧʔϓԽมΛͷ͍ͧͯ܈ؒͷಛ͕ྨࣅ͍ͯ͠Δ άϧʔϓԽมΛ আ͍ͯ܈͕ྨࣅ͠ ͍ͯΔ͜ͱͷΤϏ σϯε͕ࣔ͞Εͯ ͍Δ ྨࣅ͍ͯ͠Δ͜ͱ ͕ݴٴ͞Ε͍ͯΔ ͕ΤϏσϯεࣔ ͞Ε͍ͯͳ͍ ྨࣅ͍ͯ͠Δͷ͔ ෆ໌֬ ྨࣅ͍ͯ͠ͳ͍ 2. σʔλղੳʹదͳํ๏͕༻͍ΒΕ͍ͯΔ͔ ͘ΒΕ͍ͯΔɺ ͋Δ͍Α͘ਖ਼ Խ͞Ε͍ͯΔํ๏ Λ༻͍͍ͯΔ దͳํ๏ͩͱ ఆ͞ΕΔ͕໌֬ʹ ड़ΒΕ͍ͯͳ͍ ద͔Ͳ͏͔ෆ໌ ֬ ෆదͳํ๏ -
ff ffi 19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ
(doubtful) ෆద (inadequate) 3. αϯϓϧαΠζద͔ ճؼੳ IRT/Rash basedͳੳ (DIFͷݕग़) ֤܈ 200 ֤܈ 150 ֤܈ 100 ֤܈ < 100 ଟूஂCFA ߲ͷ7ഒ ≧100Ҏ্ গͳ͘ͱ߲ ͷ5ഒ͔ͭ ≧100 or ߲ͷ5-7ഒ ͔ͭ<100 ߲ͷ5ഒ <100ҎԼ ߲ͷ5ഒҎ Լ -
AJL SRdVU ff 5 UZqVcV eZR ZeV Wf TeZ <A>%
• – w ffi <A> v hRp://www.jstatsor.org/v39/i08/paper -
AJL SRdVU ff Uniform DIF ( ) (or ) non-Uniform
DIF ( ) ) ( ) ) ( ) Psychol Sci Q. 2008 ; 50(4): 538. hRp://www.restore.ac.uk/appliedpsychometrics/Tutorial.materials/Measurement.invariance/ DIF%20workshop%202012%20FINAL.pdf α( ) β ( ) -
AJL SRdVU ff PSFKOCM MPIKTUKE SGISGTTKPO : baseline model non-uniform
DIF uniform DIF ( ) DIF : → (χ2) uniform DIFͷݕग़: base model vs uniform DIF non-uniform DIFͷݕग़: uniform DIF vs non-uniform DIF total DIFͷݕग़: base model vs non-uniform DIF pseudo R2 (ٖࣅܾఆ): ࢄઆ໌R2 Δβ: baseline model uniform DIF model β (baseline β - uniform β) / uniform β 10% (prac:cal) (Crane et al. 2004) → pseudo R2, ΔR2 Zumbo (1999) : 0.13 = (negligible) 0.13 0.26 = (moderate) 0.26 = (large) -
K E % • E UV ,5 n fcR Z
gRcZR TV – • E UV -5 EVecZT Z gRcZR TV – • E UV .5 KTR Rc Z gRcZR TV – • E UV /5 cVdZUfR Z gRcZR TV – 19/08/31 WS Model1 4 ΔCFI = 0.01 model2 -
n fcR A gRcZR TV • ff % ूஂ̍ item
5 item 6 item 2 item 1 item 3 item 4 f1 f2 ूஂ2 item 5 item 6 item 2 item 1 item 3 item 4 f1 f2 ্هͷϞσϧਤͷ߹ɺूஂؒͰҼࢠߏ͕ҟͳΔ (Configural Invariance͕ຬͨ͞Ε͍ͯͳ͍) -
EVecZT A gRcZR TV • ff ूஂ̍ item 5 item
6 item 2 item 1 item 3 item 4 f1 f2 ूஂ̎ item 5 item 6 item 2 item 1 item 3 item 4 f1 f2 ্هͷϞσϧਤͷ߹ɺूஂؒͰҼࢠෛՙ͕ҟͳΔ (Metric invariance͕ຬͨ͞Ε͍ͯͳ͍) -
19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ (doubtful) ෆద
(inadequate) 1. ױऀͷଌఆ֓೦͕Ұఆͷظؒ҆ఆ͍ͯ͠Δ 2. ִؒద͔ 3.ςετ͕݅ଌఆػձؒͰಉ͔͡ -
T e)% 19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ
(doubtful) ෆద (inadequate) 4. ࿈ଓईͷ߹: ڃ૬͕ؔࢉग़͞Ε͍ͯΔ͔ ICC͕ࢉग़͞Εɺ ICCͷ͕ࣜهࡌ ͞Ε͍ͯΔ ICC͕ࢉग़͞Ε ͍ͯΔ͕ɺܭࢉ ࣜෆ໌·ͨ ෆద ܥ౷తͳมԽ͕ ੜ͍ͯ͡ͳ͍͜ ͱͷΤϏσϯε ͕ࣔ͞ΕΔͱͱ ʹ૬ؔΛ ༻͍ͯΔ ܥ౷తͳมԽ͕ ੜ͍ͯ͡ͳ͍͜ ͱͷΤϏσϯε Λࣔͣ͞ɺ૬ؔ Λ༻͍ͯΔ ܥ౷తͳมԽ͕ ੜ͍ͯ͡Δ͜ͱ ͷΤϏσϯεΛ ࣔͯ͠૬ؔ Λ༻͍͍ͯͳ͍ ICC૬ؔ ࢉग़͞Ε͍ͯ ͳ͍ -
T e)% 19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ
(doubtful) ෆద (inadequate) 5. ΧςΰϦΧϧईͷ߹: kappa͕ࢉग़͞Ε͍ͯΔ͔ KappaΛࢉ ग़͍ͯ͠Δ ࢉग़͍ͯ͠ͳ͍ 6. ॱংईͷ߹ɿॏΈ͚kappa͕ࢉग़͞Ε͍ͯΔ͔ ॏΈ͚Kappa Λࢉग़ͯ͠ ͍Δ ॏΈ͚͍ͯͳ ͍KappaΛ ࢉग़͍ͯ͠Δ· ͨهࡌ͕ͳ͍ 7. ॱংईͷ߹ɿॏΈ͚ͷεΩʔϜ͕ड़ΒΕ͍ͯΔ͔ ॏΈ͚εΩʔ Ϝ͕هࡌ͞Εͯ ͍Δ ॏΈ͚εΩʔ Ϝ͕هࡌ͞Εͯ ͍ͳ͍ -
ffi 19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ (doubtful)
ෆద (inadequate) 1. ױऀͷଌఆ֓೦͕Ұఆͷظؒ҆ఆ͍ͯ͠Δ 2. ִؒద͔ 3.ςετ͕݅ଌఆػձؒͰಉ͔͡ 1 -
ffi T e)% 19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate)
ඍົ (doubtful) ෆద (inadequate) 4. ࿈ଓईͷ߹: ࢦඪͷඪ४ޡࠩ(SEM), ࠷খݶͷݕग़Մೳ ͳมԽ (SDC), Ұகݶք (LoA)͕ࢉग़͞Ε͍ͯΔ͔ SEM, SDC, or LoA LoA SEM Cronbach alpha SD 5.ΧςΰϦΧϧईͷ߹:Ұக͕ࢉग़͞Ε͍ͯΔ -
ffi K E% K< D 9 • K< % •
D 9 https://researchmap.jp/muuex8xf9-1788230/? action=multidatabase_action_main_filedownload&download_flag=1&upload_id=65193&metadata_id=49144 -
19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ (doubtful) ෆద
(inadequate) 1. ࿈ଓईͷ߹: ૬ؔɺ͋Δ͍ROCۂઢԼ໘ੵ͕ࢉग़͞Ε͍ͯΔ AUC AUC 2.2ईͷ߹: ײɾಛҟ͕ಛఆ͞Ε͍ͯΔ 3. ଞͷσβΠϯ౷ܭ๏্ͷॏཁͳ͕ܽؕ͋Δ͔ -
ffi 19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ (doubtful)
ෆద (inadequate) 1. ൺֱͱͳΔࢦඪ͕໌֬Ͱ͋Δ͔ 2. ൺֱͱͳΔࢦඪͷಛੑे͔ 3. Ծઆݕূʹదͳ౷ܭख๏Ͱ͋Δ͔ 9a) ଞͷΞτΧϜࢦඪͱൺֱ (ऩଋతଥੑ) -
ffi 19/08/31 WS ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ (doubtful)
ෆద (inadequate) 5. αϒάϧʔϓͷॏཁͳಛ͕దʹهड़͞Ε͍ͯΔ͔ 6. Ծઆݕఆͷ౷ܭख๏͕ద͔ 9b) αϒάϧʔϓؒͰͷൺֱ (หผత ·ͨknow-groups validity) -
10a) ج४Ξϓϩʔν (ΰʔϧυελϯμʔυͱͷൺ ֱ) ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ
(doubtful) ෆద (inadequate) 1. ࿈ଓईͷ߹: ૬ؔɺ͋Δ͍ROCۂઢԼ໘ੵ͕ࢉग़͞Ε͍ͯΔ AUC AUC 2.2ईͷ߹: ײɾಛҟ͕ಛఆ͞Ε͍ͯΔ -
19/08/31 10b) ֓೦Ξϓϩʔν (ଞͷΞτΧϜࢦඪͱͷൺֱ) ͱͯྑ͍ (very good) ྑ͍ (adequate) ඍົ
(doubtful) ෆద (inadequate) 4. ൺֱͱͳΔࢦඪ͕໌֬Ͱ͋Δ͔ 5. ൺֱͱͳΔࢦඪͷಛੑे͔ 6. Ծઆݕূʹదͳ౷ܭख๏Ͱ͋Δ͔ 7. ଞͷσβΠϯ౷ܭ๏্ͷॏཁͳ͕ܽؕ͋Δ͔ -
19/08/31 WS 10c) ֓೦Ξϓϩʔν (αϒάϧʔϓؒͰͷൺֱ) ͱͯྑ͍ (very good) ྑ͍ (adequate)
ඍົ (doubtful) ෆద (inadequate) 8. αϒάϧʔϓͷॏཁͳಛ͕దʹهड़͞Ε͍ͯΔ͔ 9. Ծઆݕఆͷ౷ܭख๏͕ద͔ -
19/08/31 WS 10d) ֓೦Ξϓϩʔν (հೖલޙ) ͱͯྑ͍ (very good) ྑ͍ (adequate)
ඍົ (doubtful) ෆద (inadequate) 11. ఏڙ͞Εͨհೖʹ͍ͭͯదͳهड़͕ͳ͞Ε͍ͯΔ 12. Ծઆݕఆͷ౷ܭख๏͕ద͔ -
LR V Y V VddR V • u u •
u fi • 19/08/31 WS -
k 1 - 2: 3::0 1- ? 1 1 :
1 1 GKEAF ± ʻ 3VKFGMKOG HPS YTUGNCUKE GWKG T PH :VUEPNG GCTVSGNGOU OTUSVNGOUT 19/08/31 WS -
% TcZeVcZR W c U VRdfcV V e ac aVcej%
Mokkink, L. B., De Vet, H. C., Prinsen, C. A., Patrick, D. L., Alonso, J., Bouter, L. M., & Terwee, C. B. (2018). COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Quality of Life Research, 27(5), 1171-1179. COSMINͰɺࢦඪಛੑ͝ͱʹɺ ྑ͍ईಛੑධՁͷج४͕ ໌֬ʹࣔ͞Ε͍ͯΔɻ + sufficient (े) − insufficient (ෆे) ? indeterminate (ܾΊΒΕͳ͍) ྫ) ɹత߹ੑ: ΫϩϯόοΫͷα ͕ .80Ͱsufficient? ɹߏతଥੑ: CFI ͕.90ɺRMSEA͕10Ͱsufficient? 3ΧςΰϦධఆ [+ / - / ?] -
+ CTT CFI or TLI > 0.95, RMSEA < 0.06,
SRMR < 0.08 IRT : CFA: CFI or TLI > 0.95, RMSEA < 0.06, SRMR < 0.08 : < 0.20 or Q3 < 0.37 : or item scalability >0.30 : IRT: χ2 > 0.01 Rasch: infit/outit mean squares ≥ 0.5 and ≤ 1.5 Z- standardized values > -2 and <2 − (+) / ? -
− (+) / ? + ICC or Kappa ≥ 0.70
+ Cronbach‘s alpha(s) ≥ 0.70 (+) low -
ffi • + SDC or LoA < MIC - SDC
or LoA > MIC ? SDC: : LoA: MIC: -
K< c D 9 6 EA (2014) MIC SDC (
) ( ) ( ) MDC: minimally detectable change; MIC: minimally important change MDC: 2 * 1.96 * 2 -
K< c D 9 7 EA (2014) DC MIC (
) ( ) ( ) SDC: smallest detectable change ( ); MIC: minimally important change SDC: 2 * 1.96 * 2 -
EA ffi • 2 • 2 • Angst, F., Aeschlimann,
A., & Angst, J. (2017). The minimal clinically important difference raised the significance of outcome effects above the statistical level, with methodological implications for future studies. Journal of clinical epidemiology, 82, 128-136. SD 0.30-0.50 -
ff + 0.70 AUC ≥ 0.70 + ( ) +
+ AUC ≥ 0.70 / -
LR V Y V VddR V • • ffi EA
– 19/08/31 WS -
05 Lee, J., Lee, E. H., & Moon, S. H.
(2019). Systematic review of the measurement properties of the Depression Anxiety Stress Scales–21 by applying updated COSMIN methodology. Quality of Life Research, 1-15. -
05 Lee, J., Lee, E. H., & Moon, S. H.
(2019). Systematic review of the measurement properties of the Depression Anxiety Stress Scales–21 by applying updated COSMIN methodology. Quality of Life Research, 1-15. -
1 1 -. B 21- . B 1 : 1
0- : GKEAF ± ʻ 3VKFGMKOG HPS YTUGNCUKE GWKG T PH :VUEPNG GCTVSGNGOU OTUSVNGOUT 19/08/31 WS -
Z eVcacVeRSZ Zej% • ffi – – – ʼ fi
– – fi – v • EA< u 19/08/31 WS -
h k k b – • • u • u
( ( EZ Z R j A a ceR e YR V EA % ( JVda dV KYZWe JK% ( ( ( ffi 19/08/31 WS -
WVRdZSZ Zej • ffi – HJG 19/08/31 WS feasibilityͷཁૉ -
ױऀͷΘ͔Γ͢͞, ྟচՈͷΘ͔Γ͢͞ - ࣮ࢪͷܗଶͱ༰қ͞, ࢦඪͷ͞, ॴ༻࣌ؒ - ױऀʹඞཁͳਫ਼ਆɺମతೳྗ, - ඪ४Խͷ༰қ͞, ࢦඪܭࢉͷ༰қ͞ - ஶ࡞ݖ, ࢦඪͷίετ - ඞཁͳஔ, ҟͳΔηοςΟϯάͰͷೖखՄೳੑ - ڐՄൃߦௐػؔ ղऍՄೳੑfeasibilityɺࢦඪબͷଆ໘ͱͯ͠ॏཁ ͕ͩɺࢦඪಛੑͰͳ͍ɻ -
• ffi – ffi ffi ffff u HJG u fi
u – v – – v -
• TYR V aVcd R gR fVd% հೖલ item 5
item 6 item 2 item 1 item 3 item 4 f1 f2 հೖޙ item 5 item 6 item 2 item 1 item 3 item 4 f1 f2 -
• cVT decfTeZ % հೖલ item 5 item 6 item
2 item 1 item 3 item 4 f1 f2 հೖޙ item 5 item 6 item 2 item 1 item 3 item 4 f1 f2 -
• հೖલ item 5 item 6 item 2 item 1
item 3 item 4 f1 f2 հೖޙ item 5 item 6 item 2 item 1 item 3 item 4 f1 f2 ( ) (uniform recalibra:on) (non-uniform recalibra:on) -
High -1 Serious -2 Very serious -3 Extremely serious -1
Serious -2 Very serious ( ) -1 total n=50-100 -2 total n<50 ( ) -1 Serious -2 Very serious moderate low Very low -
No adequate very good Serious doubtul adequate Very serious inadequate
doubtul Extremely Serious Inadequate 19/08/31 WS -
LR V Y V VddR V • u u WVRdZSZ
Zeju • ufi • 19/08/31 WS